These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 11726314

  • 1. Blood cells diseases and thrombosis.
    Leone G, Sica S, Chiusolo P, Teofili L, De Stefano V.
    Haematologica; 2001 Dec; 86(12):1236-44. PubMed ID: 11726314
    [Abstract] [Full Text] [Related]

  • 2. Relation of platelet abnormalities to thrombosis and hemorrhage in chronic myeloproliferative disorders.
    Wehmeier A, Südhoff T, Meierkord F.
    Semin Thromb Hemost; 1997 Dec; 23(4):391-402. PubMed ID: 9263357
    [Abstract] [Full Text] [Related]

  • 3. Hypercoagulability and tissue factor gene upregulation in hematologic malignancies.
    Falanga A, Barbui T, Rickles FR.
    Semin Thromb Hemost; 2008 Mar; 34(2):204-10. PubMed ID: 18645927
    [Abstract] [Full Text] [Related]

  • 4. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses.
    Morel O, Morel N, Freyssinet JM, Toti F.
    Platelets; 2008 Feb; 19(1):9-23. PubMed ID: 18231934
    [Abstract] [Full Text] [Related]

  • 5. Pathogenesis of thrombosis in essential thrombocythemia and polycythemia vera: the role of neutrophils.
    Falanga A, Marchetti M, Barbui T, Smith CW.
    Semin Hematol; 2005 Oct; 42(4):239-47. PubMed ID: 16210037
    [Abstract] [Full Text] [Related]

  • 6. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
    Michiels JJ, Berneman Z, Van Bockstaele D, van der Planken M, De Raeve H, Schroyens W.
    Semin Thromb Hemost; 2006 Apr; 32(3):174-207. PubMed ID: 16673274
    [Abstract] [Full Text] [Related]

  • 7. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
    De Stefano V, Za T, Rossi E, Vannucchi AM, Ruggeri M, Elli E, Micò C, Tieghi A, Cacciola RR, Santoro C, Gerli G, Vianelli N, Guglielmelli P, Pieri L, Scognamiglio F, Rodeghiero F, Pogliani EM, Finazzi G, Gugliotta L, Marchioli R, Leone G, Barbui T, GIMEMA CMD-Working Party.
    Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
    [Abstract] [Full Text] [Related]

  • 8. Lactadherin and procoagulant activities of red blood cells in cyclosporine induced thrombosis.
    Zheng YN, Yu HJ, Hou JX, Lu CF, Zhou J.
    Chin Med J (Engl); 2009 Jul 20; 122(14):1674-80. PubMed ID: 19719970
    [Abstract] [Full Text] [Related]

  • 9. Daunorubicin induces procoagulant response through phosphatidylserine exposure in red blood cells.
    Zhou J, Zheng Y, Shi J, Lu C, Hou J, Yu H, Qiao X, Qi S, Gilbert GE.
    Thromb Res; 2010 Feb 20; 125(2):178-83. PubMed ID: 19800661
    [Abstract] [Full Text] [Related]

  • 10. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia.
    Michiels JJ, Berneman Z, Schroyens W, Koudstaal PJ, Lindemans J, Neumann HA, van Vliet HH.
    Platelets; 2006 Dec 20; 17(8):528-44. PubMed ID: 17127481
    [Abstract] [Full Text] [Related]

  • 11. Coagulation and splenectomy: an overview.
    Cappellini MD, Grespi E, Cassinerio E, Bignamini D, Fiorelli G.
    Ann N Y Acad Sci; 2005 Dec 20; 1054():317-24. PubMed ID: 16339680
    [Abstract] [Full Text] [Related]

  • 12. Lead-induced procoagulant activation of erythrocytes through phosphatidylserine exposure may lead to thrombotic diseases.
    Shin JH, Lim KM, Noh JY, Bae ON, Chung SM, Lee MY, Chung JH.
    Chem Res Toxicol; 2007 Jan 20; 20(1):38-43. PubMed ID: 17226925
    [Abstract] [Full Text] [Related]

  • 13. Thrombotic complications in essential thrombocythemia (ET): clinical facts and biochemical riddles.
    Petrides PE, Siegel F.
    Blood Cells Mol Dis; 2006 Jan 20; 36(3):379-84. PubMed ID: 16563815
    [Abstract] [Full Text] [Related]

  • 14. Oxidative status of red blood cells, neutrophils, and platelets in paroxysmal nocturnal hemoglobinuria.
    Amer J, Zelig O, Fibach E.
    Exp Hematol; 2008 Apr 20; 36(4):369-77. PubMed ID: 18261835
    [Abstract] [Full Text] [Related]

  • 15. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
    Michiels JJ, Berneman Z, Schroyens W, Finazzi G, Budde U, van Vliet HH.
    Semin Thromb Hemost; 2006 Sep 20; 32(6):589-604. PubMed ID: 16977569
    [Abstract] [Full Text] [Related]

  • 16. Thrombosis and bleeding in polycythemia vera and essential thrombocythemia: pathogenetic mechanisms and prevention.
    Landolfi R, Cipriani MC, Novarese L.
    Best Pract Res Clin Haematol; 2006 Sep 20; 19(3):617-33. PubMed ID: 16781491
    [Abstract] [Full Text] [Related]

  • 17. Hyperviscosity in polycythemia vera and other red cell abnormalities.
    Kwaan HC, Wang J.
    Semin Thromb Hemost; 2003 Oct 20; 29(5):451-8. PubMed ID: 14631544
    [Abstract] [Full Text] [Related]

  • 18. Clotting mechanisms and cancer: implications in thrombus formation and tumor progression.
    Falanga A, Marchetti M, Vignoli A, Balducci D.
    Clin Adv Hematol Oncol; 2003 Nov 20; 1(11):673-8. PubMed ID: 16258469
    [Abstract] [Full Text] [Related]

  • 19. Screening for inherited thrombophilia: indications and therapeutic implications.
    De Stefano V, Rossi E, Paciaroni K, Leone G.
    Haematologica; 2002 Oct 20; 87(10):1095-108. PubMed ID: 12368166
    [Abstract] [Full Text] [Related]

  • 20. Platelet activation and red blood cell phosphatidylserine exposure evaluated by flow cytometry in patients with Behçet's disease: are they related to thrombotic events?
    Martínez M, Ricart JM, Ruiz-Aja S, Rus A, Todolí J, Calvo J, Vayá A.
    Pathophysiol Haemost Thromb; 2007 Oct 20; 36(1):18-22. PubMed ID: 18332610
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.